After exercising options, United Therapeutics (UTHR) CEO sells 9,500 shares through family trusts.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
United Therapeutics Corp. (UTHR) Chairperson & CEO Martine A. Rothblatt exercised 9,500 stock options on October 21, 2026, at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context